Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 15, 2025Frontiers in MedicineOpen Access

A study on the pharmacovigilance of various SGLT-2 inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

YDYanwen DongYWYangyang WangXLXiao-mei Lan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dong et al. (2025) studied this question.

synapsesocial.com/papers/69d6fc13a0177bf533ed978bhttps://doi.org/10.3389/fmed.2024.1515847
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sodium‐glucose co‐transporter‐2 inhibitors and the risk of urosepsis: A multi‐site, prevalent new‐user cohort study2020 · 34 citations
  2. 2Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database2024 · 15 citations
  3. 3SGLT2-inhibition increases total, LDL, and HDL cholesterol and lowers triglycerides: Meta-analyses of 60 randomized trials, overall and by dose, ethnicity, and drug type2023 · 83 citations
  4. 4Impact of SGLT2 inhibitors on lower limb complications: a mendelian randomization perspective2024 · 2 citations
  5. 5Prevalence of self-reported sleep duration and sleep habits in type 2 diabetes patients in South Trinidad2015 · 78 citations